Leadership

Marzena Jurek, M.S., joined Pliant in March 2019 and oversees the tactical implementation of Pliant’s clinical programs. She brings to Pliant 20 years of broad experience in clinical development and pre-clinical research in mid and small/start-up companies. Ms. Jurek previously oversaw and managed early and late-stage global programs in several rare disease indications, including hepatic encephalopathy, idiopathic pulmonary fibrosis, and sickle cell disease. She has held positions of increasing responsibility at Portola Pharmaceuticals, Hyperion Therapeutics, and most recently Global Blood Therapeutics, among others, managing cross-functional teams and overseeing the deployment of clinical programs.